Literature DB >> 15642858

A clinical, magnetic resonance imaging, and survival motor neuron gene deletion study of Hirayama disease.

U K Misra1, J Kalita, V N Mishra, A Kesari, B Mittal.   

Abstract

BACKGROUND: Hirayama disease (HD) is a segmental nonprogressive spinal muscular atrophy found in male patients.
OBJECTIVE: To report the results of a comprehensive evaluation of clinical, magnetic resonance imaging (MRI), electromyography (EMG), and survival motor neuron (SMN) gene analysis of HD.
DESIGN: Clinical, MRI, and SMN gene deletion study.
SETTING: Tertiary care teaching hospital. PATIENTS: Patients with HD diagnosed according to defined criteria were included in the study.
INTERVENTIONS: Patients underwent a neurologic evaluation and pedigree charting. Concentric needle EMG was performed on a number of muscles. Motor nerve conduction study of the median, ulnar, and peroneal nerves and sensory conduction study of the median, ulnar, and sural nerves were also performed. Spinal MRI of the cervical region was performed with the 2-T scanner operating at 1.5 T. Gene deletion study of SMN1 and SMN2 was performed in all patients. MAIN OUTCOME MEASURES: History of trauma, occupation, exercise, associated medical disease, and cold paresis and muscle wasting, power, reflex changes, and tone.
RESULTS: Fifteen male patients with HD from 14 families participated in the study (mean age at the onset of disease, 18 years; range, 15-23 years). Muscle weakness and wasting were noted in the right upper limb in 12 and the left upper limb in 3, which became bilateral in 8 patients. Cold paresis was present in 6 patients and polyminimyoclonus in all patients. The EMG revealed fibrillations in 10, fasciculations in 15, and neurogenic motor unit potentials in C7, C8, and T1 myotomes in all patients. The EMG abnormalities were unilateral in 5, bilateral in 10, and subclinical in 2 patients. Spinal MRI revealed cord atrophy in 3 of 11 patients. Although family history was present in 1 brother only, the results of both SMN1 and SMN2 gene deletion studies were negative in all patients.
CONCLUSIONS: The SMN gene deletion is not found in HD. Exclusive occurrence in male patients and the presence of this disease in 2 brothers suggest a possible role of the X chromosome, which needs further evaluation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642858     DOI: 10.1001/archneur.62.1.120

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

1.  Effect of neck flexion on F wave, somatosensory evoked potentials, and magnetic resonance imaging in Hirayama disease.

Authors:  U K Misra; J Kalita; V N Mishra; R V Phadke; A Hadique
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

2.  A multiparametric brain and cord MR imaging study of a patient with Hirayama disease.

Authors:  A Gallo; M A Rocca; P Tortorella; A Ammendola; G Tedeschi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

3.  Juvenile Muscular Atrophy of a Unilateral Upper Extremity (Hirayama Disease) in a Patient with CHARGE Syndrome.

Authors:  T Yagihashi; K Hatori; K Ishii; C Torii; S Momoshima; T Takahashi; K Kosaki
Journal:  Mol Syndromol       Date:  2010-06-30

Review 4.  [Hirayama disease in Germany: case reports and review of the literature].

Authors:  J-S Kang; S Jochem-Gawehn; H Laufs; A Ferbert; P Vieregge; U Ziemann
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

5.  Finger trembling improvement after surgery in Hirayama disease: a case report.

Authors:  Nobuaki Tadokoro; Kyuichi Hashimoto; Katsuhito Kiyasu; Yusuke Kasai; Naoki Aoyama; Ryuichi Takemasa; Masahiko Ikeuchi
Journal:  Spinal Cord Ser Cases       Date:  2022-04-25

6.  Is congenital melanocytic naevus a link between Hirayama disease and moyamoya pattern: a new syndrome or a co-incidence?

Authors:  Inder Puri; Deepti Vibha; Kameshwar Prasad; Rohit Bhatia
Journal:  BMJ Case Rep       Date:  2016-01-08

7.  Mutational analysis of glycyl-tRNA synthetase (GARS) gene in Hirayama disease.

Authors:  Sergiu C Blumen; Vivian E Drory; Menachem Sadeh; Baruch El-Ad; Uri Soimu; Galina B Groozman; Jean-Pierre Bouchard; Lev G Goldfarb
Journal:  Amyotroph Lateral Scler       Date:  2010

8.  Somatosensory evoked potentials and Hirayama disease.

Authors:  Adeel Shakil Zubair; Brian Crum
Journal:  Surg Neurol Int       Date:  2021-04-26

9.  Fasciculations masquerading as minipolymyoclonus in bulbospinal muscular atrophy.

Authors:  Sushanth Bhat; Wei Ma; Elena Kozochonok; Sudhansu Chokroverty
Journal:  Ann Indian Acad Neurol       Date:  2015 Apr-Jun       Impact factor: 1.383

Review 10.  Nosology of juvenile muscular atrophy of distal upper extremity: from monomelic amyotrophy to Hirayama disease--Indian perspective.

Authors:  Kaukab Maqbool Hassan; Hirdesh Sahni
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.